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NO EVIDENCE OF VERTICAL TRANSMISSION OF HTLV-I IN BOTTLE-FED CHILDREN
Achiléa L BITTENCOURT(1), Ester C. SABINO(2), Maria Cecília COSTA(3), Celia PEDROSO(4) & Licia MOREIRA(5)
SUMMARY
The most frequent pathway of vertical transmission of HTLV-I is breast-feeding, however bottle fed children may also become
infected in a frequency varying from 4 to 14%. In these children the most probable routes of infection are transplacental or contamination
in the birth canal.
Forty-one bottle-fed children of HTLV-I seropositive mothers in ages varying from three to 39 months (average age of 11 months)
were submitted to nested polymerase chain reaction analysis (pol and tax genes). 81.5% of the children were born by an elective
cesarean section.
No case of infection was detected. The absence of HTLV-I infection in these cases indicates that transmission by transplacental
route may be very infrequent.
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INTRODUCTION
The most frequent pathway of vertical transmission of HTLV-I is
breast-feeding. Through prenatal screening for HTLV-I and the refraining
from breast-feeding for the carrier mothers a reduction of ~ 80% of
vertical transmission has been observed in Japan5. Serologic surveys of
breast-fed children of carrier mothers using different methods of detection
reported infection rates varying from 10% to 28% and indicate that the
rate of transmission is directly related to the time of breast-feeding5-
7,15,18,20
. However bottle-fed children may also become infected vertically
in a frequency varying from 4% to 14%5-7,15,18,20.
Besides breast-feeding the other possible mechanisms of vertical
transmission of infections are: transplacental or hematogenous, by
ascending microrganisms from the vagina (ascending via), by fetus
contamination in the birth canal during delivery or by intimate contact
between mother and child. The mechanism of vertical transmission of
HTLV-I in bottle-fed infants remains to be established, however the most
probable routes of infection may be transplacental or contamination in
birth canal. Many researchers have shown that elective cesarian delivery
reduces mother–to–child transmission in other blood born viral infections
mainly because direct contact with blood is avoided4,8,11-13,19. On the other
hand, in labor uterine contractions can disrupt the placental barrier
resulting in transplacental microtransfusions from mother to fetus. It
has been shown that maternal microtransfusion to the fetus can be affected
by different modes of delivery, but elective cesarean presents the least
microtransfusion risk11.
Considering these facts, we decided to evaluate the vertical
transmission of HTLV-I in breast-fed children born through elective
cesarean section.
MATERIAL AND METHODS
The mothers were screened serologically for HTLV-I through ELISA
and Western blot. The methods of screening were detailed in another
paper2. The mothers were informed about the research and those who
consented were submitted to cesarean section and were advised to refrain
from breast-feeding. Pediatric assistance and an alternative nutritional
supply were provided for the babies. Testing for HTLV-I DNA was
performed by nested polymerase chain reaction (PCR) on peripheral
blood mononuclear cells of forty-one bottle-fed children. Permission
was obtained from all the mothers of the children included in this study.
PCR testing: Mononuclear cells were isolated from peripheral blood
of children by density centrifugation through Ficoll-Conray gradient.
The peripheral blood mononuclear cells pellet was washed twice with
0.9% NaCl and re-suspended in 100 µl of lysis buffer (10 mM Tris-
buffer [pH 8.3], 0.5% Nonidet P-40, 0.5% Tween 20) and digested with
40 µg of proteinase K at 65 oC for 2 hours. All samples were subjected to
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PCR amplification for HTLV tax gene. Due to technical problems, we
could only perform PCR for the pol gene on 28 of the 41 samples. For
the pol gene, 1 µg of DNA was amplified in one round with primers
SK110 (4384-4405 5´CCCTACAATCAACCAGCTCAG) and SK111
(4569-4547 5´GTGGTGAAGCTGCCATCGGGTTTT) in a reaction
mixture containing 3.0 mM MgCl2 and 0.2 mM each primer. The PCR
product was detected by liquid hybridization with a radio labeled probe
SK112 (4452-4573 5´GTACTTTACTGACAAACCCGACCTAC) for
HTLV-I. To detect the tax gene, DNA was amplified by a nested PCR
with SK43 (6985-7003 5´CGGATACCCAGTCTACGT) and SK44
(7143-7123 5´GAGCCGATAACGCGTCCATCG) in the first round and
TAX1 (7001-7020 5’-GTGTTTGGCGATTGTGTACA-3’) and TAX2
(7128-7112 5’– CCATCGATGGGGTCCCA-3’) in the second round in
a reaction mixture containing 2.5 mM MgCl2 and 0.2 mM each primer.
The PCR product was analyzed upon electrophoresis on a 1% agarose
gel16. A T-cell line (MT-2) infected with HTLV-1 was used as positive
control. PBMC from seronegative individuals were used as negative
controls. Positive and negative controls were included in every run. All
samples were also submitted to PCR for the beta globin gene to detect
the presence of PCR inhibitors.
RESULTS
From 52 HTLV-I+ mothers included in a previous study2 only forty-
one non breast-fed children could be contacted for PCR studies in ages
varying from three months to 39 months (average age of 11 months).
81.5% of the mothers have had an elective cesarean section. Sixty per
cent of these mothers were previously submitted to PCR studies with
positive results2. Four children were born prematurely and one, born at
term, was small for gestational age. Twenty-one were male and 20 were
female. None of the children received blood transfusions. PCR
amplification for the tax gene was done in all the cases and for the pol
gene in 28 cases, and the results were negative for both amplifications.
DISCUSSION
In South America there has been no evaluation of vertical
transmission of the HTLV-I until now. It is known that in Salvador, Bahia,
0.84% of pregnant women of low socioeconomic class are HTLV-I
carriers2. Furthermore, the occurrence of many cases of adult T-cell
leukemia/lymphoma1 and infective dermatitis in Salvador, Bahia3,
diseases associated with the vertical transmission of HTLV-I10,17, indicates
the importance of this route of infection in this city.
In this study the children were tested by nested PCR because this
method is more sensitive for the detection of HTLV-I infection than
conventional serology and is very useful for diagnosis of this infection
early in life, before seroconversion, that occurs between one and three
years of age5,9. In the laboratory of Molecular Biology, Fundação Pró-
Sangue/Hemocentro, USP, Brazil the sensitivity of PCR was 90% when
seropositive blood donors were used as positive controls16. Using
conventional serology MONPLAISIR et al. (1993)14 found 7% of
infection among 27 children (ages varying from 2 to 12 years) born to
HTLV-I seropositive mothers, but when they used PCR the frequency of
transmission increased to 41%.
As previously stated, bottle-fed children can be infected vertically
in a frequency varying from 4% to 14%. However, in the present study
no case of vertical transmission was observed in 41 bottle-fed children.
The absence of infection determined by a sensitive method indicates
that transmission by the transplacental route may be very infrequent. It
is possible that the artificial delivery that occurred in 81.5% of the cases
may have contributed to the absence of transmission.
RESUMO
Ausência de transmissão vertical do HTLV-I em crianças não
amamentadas
A amamentação é o meio mais freqüente de transmissão vertical do
HTLV-I. No entanto, crianças não amamentadas mostram-se infectadas
em freqüências que variam de 4 a 14%. Nestes casos, os meios mais
prováveis de infecção devem ser através da placenta ou por contaminação
no canal de parto. Quarenta e um filhos de portadoras do HTLV-I aleitados
artificialmente foram submetidos a pesquisa do vírus pela reação em cadeia
da polimerase. 81,5% destas crianças nasceram através de cesária eletiva.
Nenhum caso de infecção pelo HTLV-I foi detectado. Este fato indica que
a infecção por via transplacentária é pouco freqüente e que é provável que
o parto artificial tenha contribuído para a ausência de transmissão do vírus.
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